GST fusion expression of conotoxin MVII A gene and its use
A conotoxin, fusion expression technology, applied in the direction of DNA / RNA fragments, medical preparations containing active ingredients, hybrid peptides, etc., can solve the problems of unstable quality, difficult process, low yield, etc., and achieve convenient purification , simple process, large output effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0026] A kind of expression of embodiment 1 conotoxin MVIIA gene
[0027] Materials and Methods
[0028] 1.1 Materials and reagents
[0029] The pGEX-2T plasmid and Escherichia coli BL21 strains were stored in our laboratory; CTX gene synthesis was completed by Shanghai Sangong Bioengineering Company; T4 polynucleotide kinase (TPK), T4 DNA ligase, restriction enzyme, isopropyl sulfide Substituted-β-D-galactoside (IPTG), medium molecular weight Marker, and reduced glutathione were purchased from Shanghai Sangon Bioengineering Company; Glutathione-Sepharose 4B was purchased from Parmacia Company; other reagents were purchased from various domestic companies.
[0030] 1.2 Method
[0031] 1.2.1 Chemical synthesis of the target gene
[0032]Because the length of the CTX MVIIA polypeptide gene is shorter, the synthesis is more convenient and quick. The full sequence of CTX MVIIA was synthesized by Shanghai Sangon Bioengineering Co., Ltd., a restriction site for BamH I was introd...
Embodiment 2
[0063] Because the conotoxin MVIIA can block the N-type voltage-sensitive calcium channel of nerve cells, thereby inhibiting the transmission of pain signals, it has a wide range of analgesic effects. It can be used for acute and persistent pain, such as analgesia for patients with advanced cancer, AIDS, acute pain after surgery, burns, biliary colic patients, refractory neuralgia, etc. It can replace morphine analgesics. We use electroplate analgesia (internationally recognized model), and its effect has been proved. For the method see 1.2.6, for the result see Figure 4 , the results showed that it has high analgesic activity. It is 1000 times greater than the analgesic effect of morphine (effective dose 7.5mg / kg) reported in the anthology. Candidate as an alternative to addictive analgesics such as morphine.
Embodiment 3
[0065] In addition, conotoxins also have neuroprotective effects. When brain ischemia or mechanical trauma occurs, conotoxin MVIIA can block N-type voltage-sensitive calcium ion channels in nerve cells, thereby inhibiting stimulating neurotransmitters. The release of pathogenic calcium ions and the entry of pathogenic calcium ions into nerve cells may be used as a protective agent for brain injury, which can be used for the development of cerebral ischemia or mechanical trauma protective drugs [11-13] .
[0066] Some references involved in the present invention 1. Baldomero M, Olivera, Lourdes J, Cruz Conotoxins, in retrospect Toxicon 2001; 39:7-142. Olivera BM, Rivier J, Clark C, et al.Diversity of conus neuropeptides.J Science , 1990, 249: 13383. Olivera BM, Miljanick GP, Ramachandran J, et al. Calcium channel diversity and
[0067] neurotransmitter release: the omega-conotoxins and omega-agatoxins.
[0068] J. Annu. Rew. Biochem, 1994, 63: 823-8674. Sambrook J, Fritsch EF...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com